Tran, K., Asakawa, K., Cimon, K., Moulton, K., Kaunelis, D., Pipe, A., & Selby, P. (2010) Pharmacologic-based Strategies for Smoking Cessation: Clinical and Cost-Effectiveness Analyses. Ottawa: Canadian Agency for Drugs and Technologies in Health. Retrieved from: http://www.cadth.ca/index.php/en/hta/reports-publications/search?&type=16.
The Canadian Agency for Drugs and Technologies in Health (CADTH) conducted a review to evaluate the clinical and cost-effectiveness of pharmacologic agents for smoking cessation.
To help policy-makers, health care providers, and consumers make well-informed decisions, our completed research and findings provide:
* an examination of clinical effectiveness and cost-effectiveness based on the most recent evidence available in the public domain
* identification of planning and equity issues associated with optimal treatment strategies.